We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Investment Bank is making available up to $113 million in financing for BioNTech’s BNT162, a messenger RNA-based vaccine, and the scaling up of manufacturing capacity for it in Europe. Read More
Maryland-based Emergent BioSolutions has signed an $87 million contract with AstraZeneca to support development and production of the UK company’s COVID-19 vaccine, one of the leading candidates in the global race for an effective product. Read More
The FDA has approved a new label for Novartis’ wet age-related macular degeneration (AMD) treatment Beovu (brolucizumab) with added safety information. Read More
Attorneys general from all 50 states have filed a lawsuit against dozens of generic drugmakers alleging price fixing for more than 80 topical drugs. Read More
Fujifilm said it plans to invest $928 million to double production capacity at its biologics manufacturing facility in Denmark to supply bulk drug substances for future COVID-19 therapies and other products. Read More